BioMarin Receives Positive CHMP Opinion in Europe for Vosoritide for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
https://finance.yahoo.com/news/biomarin-receives-positive-chmp-opinion-112900280.html
Home heardonstreet BioMarin Receives Positive CHMP Opinion in Europe for Vosoritide for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close – chatter @ #wallstreetbets